Modern medicine has made significant advances in cancer treatments over the decades. But all cancer therapies still face one ...

The nucleolus is a liquid-like cellular organelle where protein factories called ribosomes are assembled. Researchers knew of ...

Researchers at the University of Liverpool have discovered that SYCP1, a protein previously thought to function only during ...

Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors ...

Des Moines University Medicine and Health Sciences faculty member Elitsa Ananieva, PhD, has led a study that could help improve the effectiveness of cancer immunotherapies by ...

Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and ...

IFLScience recently spoke with Professor Florian Markowetz, Professor of Computational Oncology at the University of ...

The epigenetic modifier MLL4 has an unassuming name-the 4, for instance, indicates it's just one in a family of such ...

Cancer Support Community at Gilda’s Club is hosting an informative and supportive workshop to discuss the biology of cancer.

A new study challenges a 60-year-old assumption about the body’s main structural building block, opening new possibilities ...

Pancreatic ductal adenocarcinoma, often called PDAC, is the most common type of pancreatic cancer and one of the deadliest cancers doctors treat. It usually grows quickly and often spreads to other ...

SpudCell marks a milestone for synthetic biology, but it is not fully alive. It will, however, help scientists answer key ...